Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Satoshi Tamada"'
Autor:
Masatoshi Eto, Toshio Takagi, Go Kimura, Satoshi Fukasawa, Satoshi Tamada, Yuji Miura, Mototsugu Oya, Naoto Sassa, Satoshi Anai, Masahiro Nozawa, Hideki Sakai, Rodolfo Perini, Wataru Yusa, Hiroki Ikezawa, Tomoyuki Narita, Yoshihiko Tomita
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 6902-6912 (2023)
Abstract Background The phase 3 CLEAR study demonstrated statistically significantly improved efficacy with lenvatinib plus pembrolizumab versus sunitinib, including progression‐free survival and overall survival, in patients with previously untrea
Externí odkaz:
https://doaj.org/article/8c1591921a074d1ba5b9e9d36660eacf
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Enzalutamide is an oral androgen receptor targeted agent that has been shown to improve survival in PREVAIL trials and has been approved for patients with chemo-naïve metastatic castration-resistant prostate cancer (CRPC). Meanwh
Externí odkaz:
https://doaj.org/article/1893e3a7992c4dd28eebba7a7bff220a
Autor:
Jumpei Asakawa, Taro Iguchi, Satoshi Tamada, Sayaka Yasuda, Noriko Ninomiya, Minoru Kato, Takeshi Yamasaki, Tetusji Ohmachi, Tatsuya Nakatani
Publikováno v:
Basic and Clinical Andrology, Vol 28, Iss 1, Pp 1-7 (2018)
Résumé Contexte L’objectif de notre étude rétrospective était d’évaluer la survie à 5 ans et le délai de transition du cancer de la prostate hormono-sensible au cancer de la prostate résistant à la castration chez des patients porteurs
Externí odkaz:
https://doaj.org/article/2835ad7708eb4d09b91a08790c60afaa
Autor:
Satoshi Tamada, Kyoko Ebisu, Sayaka Yasuda, Minoru Kato, Noriko Ninomiya, Takeshi Yamasaki, Taro Iguchi, Tatsuya Nakatani, Yasuyoshi Watanabe
Publikováno v:
Prostate International, Vol 6, Iss 2, Pp 55-60 (2018)
Background: Cancer-related fatigue is one of the most prevalent symptoms that patients with cancer experience, but the mechanisms underlying it are unknown. We aimed to quantify and mechanistically evaluate the improvement in fatigue related to admin
Externí odkaz:
https://doaj.org/article/b1018bcf9a8e4f52aff94f3c6cb4afef
Publikováno v:
Urology Case Reports, Vol 17, Iss C, Pp 79-81 (2018)
A 73-year-old woman with chief complaint of macroscopic hematuria was diagnosed as having left renal tumor with pancreatic invasion. Nephrectomy was performed. Pathological diagnosis was clear cell carcinoma, pT3a. Three months after the operation, l
Externí odkaz:
https://doaj.org/article/f77ec06d7dee407e93350a35360b530d
Autor:
Yasuomi Shimizu, Satoshi Tamada, Minoru Kato, Yukiyoshi Hirayama, Yuji Takeyama, Taro Iguchi, Marianne D. Sadar, Tatsuya Nakatani
Publikováno v:
Journal of Clinical Medicine, Vol 7, Iss 11, p 444 (2018)
Expression of androgen receptor (AR) splice variant 7 (AR-V7) has been identified as the mechanism associated with the development of castration-resistant prostate cancer (CRPC). However, a potential link between AR-V7 expression and resistance to ta
Externí odkaz:
https://doaj.org/article/52a4b266ecb648099b184d3ad636d7d1
Autor:
Tomohiro Kanamaru, Taro Iguchi, Nao Yukimatsu, Yasuomi Shimizu, Yuki Kohyama, Hirokazu Tachibana, Minoru Kato, Takeshi Yamasaki, Satoshi Tamada, Tatsuya Nakatani
Publikováno v:
Urology Case Reports, Vol 3, Iss 2, Pp 9-11 (2015)
A 68-year-old man was introduced to our hospital for the treatment of lung and mediastinum lymph node metastases that originated from an urachal carcinoma 4 years after a partial cystectomy. First-line chemotherapy with an S-1 and cisplatin combinati
Externí odkaz:
https://doaj.org/article/a6326b63e762482584e3c52338f7dd74
Autor:
Taro Iguchi, Ching Y Wang, Nicolas B Delongchamps, Minoru Kato, Satoshi Tamada, Takeshi Yamasaki, Gustavo de la Roza, Tatsuya Nakatani, Gabriel P Haas
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0131325 (2015)
To investigate whether manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with the clinical significance of prostate cancer.Prostates were obtained from 194 deceased men 45 years or older who did not have a history of prostate
Externí odkaz:
https://doaj.org/article/b68a8a80a4d8463a808ea74ea4e50864
Autor:
Satoshi Tamada, Toshihiro Asai, Nobuyuki Kuwabara, Tomoaki Iwai, Junji Uchida, Kae Teramoto, Noriko Kaneda, Tokihito Yukimura, Toshiyuki Komiya, Tatsuya Nakatani, Katsuyuki Miura
Publikováno v:
Journal of Pharmacological Sciences, Vol 100, Iss 1, Pp 17-21 (2006)
Abstract.: Tubulointerstitial fibrosis is a common feature of many progressive renal diseases and is a main determinant that leads to an irreversible loss of renal function. In chronic cyclosporin A nephrotoxicity, we previously reported that inflamm
Externí odkaz:
https://doaj.org/article/f5566723e56c4d17b9c81d9b67bcf108
Autor:
Masatoshi Eto, Toshio Takagi, Go Kimura, Satoshi Fukasawa, Satoshi Tamada, Yuji Miura, Mototsugu Oya, Naoto Sassa, Satoshi Anai, Masahiro Nozawa, Hideki Sakai, Rodolfo Perini, Wataru Yusa, Hiroki Ikezawa, Tomoyuki Narita, Yoshihiko Tomita
Publikováno v:
Cancer medicineREFERENCES.
The phase 3 CLEAR study demonstrated statistically significantly improved efficacy with lenvatinib plus pembrolizumab versus sunitinib, including progression-free survival and overall survival, in patients with previously untreated advanced renal cel